Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2026-01-21 @ 9:59 PM
Study NCT ID:
NCT03137160
Status:
COMPLETED
Last Update Posted:
2024-02-23
First Post:
2017-04-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum
Sponsor:
Ohio State University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-05-04
Start Date Type:
ACTUAL
Primary Completion Date:
2018-08-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-08-16
Completion Date Type:
ACTUAL
First Submit Date:
2017-04-27
First Submit QC Date:
None
Study First Post Date:
2017-05-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-05-04
Results First Submit QC Date:
None
Results First Post Date:
2022-06-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-21
Last Update Post Date:
2024-02-23
Last Update Post Date Type:
ACTUAL